This story was originally published Nov. 4.
Pacific Biosciences said this week that Hong Kong-based Gene Company will distribute, market, and sell its RS instrument and related products in China and Hong Kong.
The company also said that it has shipped an RS to the Institute of Medicinal Plant Development, associated with the Chinese Academy of Medical Sciences and the Peking Union Medical College.
PacBio said the placement marks the company's first shipment to Asia.
The institute plans to use the RS to "to elucidate the genetic makeup of medicinal plants and their pathogens, in order to achieve the ultimate goal of protecting and developing and utilizing medicinal resources," said Chen Shi-Lin, the director of IMPLAD.
Terms of the distributing deal with Gene Company were not disclosed.